Welcome to the ALDA Pharmaceuticals Hub on AGORACOM

(Edit this message through the "fast facts" section)

Free
Message: Launching New Products at O.D.A. Meeting, April 30, 2009

Launching New Products at O.D.A. Meeting, April 30, 2009

posted on Apr 21, 2009 09:11AM
April 21, 2009
ALDA Launching New Products at O.D.A. Meeting, April 30, 2009
VANCOUVER, BRITISH COLUMBIA--(Marketwire - April 21, 2009) - ALDA Pharmaceuticals Corp. (TSX VENTURE:APH)(OTCBB:APCSF) ("the Company" or "ALDA") announces that the Company's representatives will be attending the 142nd Annual Spring Meeting ("ASM") of the Ontario Dental Association ("ODA") commencing on April 30, 2009. This meeting is the largest dental conference held in Canada and is taking place at the Metro Toronto Convention Centre. Joining over 275 other exhibitors at the ASM, ALDA will be presenting its new product line at Booth 241 to over 10,000 dentists and 25,000 dental staff.

The product line to be presented includes:

- T36(R) Disinfectant

- T36(R) Disinfectant Wipes

- T36(R) Antiseptic Hand Sanitizer Gel

- T36(R) Antiseptic Hand Sanitizer Wipes

- T36(R) Disinfectant Cleaner CONCENTRATE

Additional products that will be introduced after the meeting include T36(R) Antiseptic Hand Sanitizer Liquid and T36 Disinfex(TM) Disinfectant Cleaner.

Dr. Terrance Owen, President & CEO, states, "We have been working towards a coordinated launch of all of ALDA's products at this show for some time. All the pieces have come together for us to undertake a major promotion of the Company products to the dental industry at this gathering. We want to move forward to other markets as soon as possible thereafter by bolstering our sales and marketing expertise and seeking out new distributors that can tackle all the other markets we see for the T36(R) technology."

Delegates to the ASM are invited to visit ALDA at Booth 241 to meet with company representatives and receive samples of the new products.

About ALDA Pharmaceuticals Corp.

ALDA is focused on the development of infection-control therapeutics derived from its patented T36(R) technology. The company trades on the TSX Venture Exchange under the symbol APH and in the U.S. on the OTCBB under the symbol APCSF.

Terrance G. Owen, Ph.D., MBA, President & CEO

ALDA Pharmaceuticals Corp.
Share
New Message
Please login to post a reply